Waiting
Elaborazione accesso...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Immunology and Infection / High-throughput Screening for Broad-spectrum…
JoVE Journal
Immunology and Infection

È necessario avere un abbonamento a JoVE per visualizzare questo Contenuto. Accedi o inizia la tua prova gratuita.

JoVE Journal Immunology and Infection
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
 

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Article DOI: 10.3791/51222-v • 11:34 min • May 5th, 2014
May 5th, 2014 •
1, 2, 2, 1, 3, 1, 1
1Unité de Génomique Virale et Vaccination, Virology Department, Institut Pasteur, CNRS UMR3569, 2Unité de Chimie et Biocatalyse, Biochemistry and Structural Biology Department, Institut Pasteur, CNRS UMR3523, 3Unité des Interactions Moléculaires Flavivirus-Hôtes, Virology Department, Institut Pasteur

Capitoli

Riepilogo
Automatic Translation

In vitro assays to measure virus replication have been greatly improved by the development of recombinant RNA viruses expressing luciferase or other enzymes capable of bioluminescence. Here we detail a high-throughput screening pipeline that combines such recombinant strains of measles and chikungunya viruses to isolate broad-spectrum antivirals from chemical libraries.

Tags

High-throughput Screening Broad-spectrum Chemical Inhibitors RNA Viruses Human Diseases Flu Bronchitis Dengue Hepatitis C Measles Emerging Threat Chikungunya Virus Epidemics Cellular Pathways Viral Replication Host Cell Functions Antiviral Compounds Host Target-oriented Assays Viral Replication In Cell Cultures Reduction Of Cytopathic Effects Screening Strategy Recombinant Viruses Reporter Enzymes Bioluminescence Luciferase High-throughput Screening Pipeline
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter